GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,544,000 | +1.4% | 426,024 | +1.5% | 0.10% | +14.6% |
| Q1 2022 | $18,280,000 | +1.6% | 419,657 | +2.8% | 0.09% | +7.2% |
| Q4 2021 | $18,000,000 | +19.1% | 408,166 | +3.2% | 0.08% | +9.2% |
| Q3 2021 | $15,119,000 | +0.6% | 395,687 | +4.8% | 0.08% | 0.0% |
| Q2 2021 | $15,035,000 | +15.1% | 377,580 | +3.2% | 0.08% | +5.6% |
| Q1 2021 | $13,062,000 | +4.2% | 365,982 | +7.4% | 0.07% | -5.3% |
| Q4 2020 | $12,541,000 | +0.6% | 340,793 | +2.9% | 0.08% | -6.2% |
| Q3 2020 | $12,470,000 | -5.0% | 331,286 | +2.9% | 0.08% | -14.7% |
| Q2 2020 | $13,127,000 | +3.0% | 321,826 | -4.3% | 0.10% | -9.5% |
| Q1 2020 | $12,743,000 | -19.4% | 336,325 | -0.1% | 0.10% | +2.9% |
| Q4 2019 | $15,817,000 | +22.4% | 336,598 | +11.1% | 0.10% | +13.3% |
| Q3 2019 | $12,926,000 | +4.9% | 302,866 | -1.6% | 0.09% | +11.1% |
| Q2 2019 | $12,318,000 | -1.4% | 307,789 | +2.9% | 0.08% | -8.0% |
| Q1 2019 | $12,495,000 | +14.5% | 298,988 | +4.7% | 0.09% | +1.1% |
| Q4 2018 | $10,917,000 | -6.3% | 285,701 | -1.5% | 0.09% | +6.1% |
| Q3 2018 | $11,650,000 | +4.0% | 290,007 | +4.4% | 0.08% | -2.4% |
| Q2 2018 | $11,202,000 | -0.8% | 277,884 | -3.9% | 0.08% | -2.3% |
| Q1 2018 | $11,296,000 | +17.6% | 289,114 | +6.9% | 0.09% | +13.2% |
| Q4 2017 | $9,604,000 | -17.0% | 270,544 | -5.1% | 0.08% | -22.4% |
| Q3 2017 | $11,578,000 | -2.5% | 285,172 | +3.6% | 0.10% | -7.5% |
| Q2 2017 | $11,871,000 | +7.8% | 275,310 | +5.4% | 0.11% | +2.9% |
| Q1 2017 | $11,016,000 | +12.5% | 261,281 | +2.8% | 0.10% | +8.4% |
| Q4 2016 | $9,791,000 | -12.0% | 254,247 | -1.4% | 0.10% | -12.0% |
| Q3 2016 | $11,125,000 | +1.3% | 257,950 | +1.0% | 0.11% | -3.6% |
| Q2 2016 | $10,982,000 | +6.3% | 255,400 | +0.3% | 0.11% | -1.8% |
| Q1 2016 | $10,330,000 | +3.8% | 254,758 | +3.3% | 0.11% | 0.0% |
| Q4 2015 | $9,948,000 | +4.7% | 246,545 | -0.3% | 0.11% | 0.0% |
| Q3 2015 | $9,505,000 | -4.1% | 247,193 | +3.8% | 0.11% | -0.9% |
| Q2 2015 | $9,915,000 | -12.6% | 238,057 | -3.2% | 0.12% | -17.3% |
| Q1 2015 | $11,345,000 | +405.6% | 245,830 | +368.1% | 0.14% | +717.6% |
| Q4 2014 | $2,244,000 | +92.3% | 52,512 | +106.9% | 0.02% | -15.0% |
| Q3 2014 | $1,167,000 | -2.4% | 25,382 | +13.5% | 0.02% | -9.1% |
| Q2 2014 | $1,196,000 | -20.3% | 22,358 | -20.4% | 0.02% | -31.2% |
| Q1 2014 | $1,500,000 | +549.4% | 28,083 | +549.3% | 0.03% | +300.0% |
| Q4 2013 | $231,000 | -66.7% | 4,325 | -68.7% | 0.01% | -63.6% |
| Q3 2013 | $694,000 | +112.2% | 13,825 | +111.6% | 0.02% | +144.4% |
| Q2 2013 | $327,000 | – | 6,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |